Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

Published: 24 November 2021| Version 2 | DOI: 10.17632/4bmkxb4r2x.2
Contributor:
Arjun Puranik

Description

These are the scripts (+ supplement) used in the analysis for the paper "Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection" Puranik, Lenehan et al. *v2: added the paper supplement

Files

Institutions

Mayo Clinic Research

Categories

Epidemiology, COVID-19

License